CAPR
CAPRICOR THERAPEUTICS, INC.
CAPRICOR THERAPEUTICS, INC. (CAPR) has 8 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 30, 2026.
The most active filer is EVP, GENERAL COUNSEL Krasney Karen with 4 filings. Insiders have net sold $3.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Linda Marbán
- Employees:231
- HQ:San Diego, CA, US
- IPO:2007-02-13
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP, GENERAL COUNSEL | Sale | 24,100 | $732K | Jun 30 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 24,100 | $732K | Jun 30 | SEC ↗ | |
| EVP, GENERAL COUNSEL | Sale | 500 | $15K | Jun 25 | SEC ↗ | |
| EVP, GENERAL COUNSEL | Sale | 400 | $12K | Jun 25 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 500 | $15K | Jun 25 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 400 | $12K | Jun 25 | SEC ↗ | |
Krasney KarenFirst filing | EVP, GENERAL COUNSEL | Sale | 25,000 | $793K | May 4 | SEC ↗ |
Bergmann AnthonyFirst filing | CHIEF FINANCIAL OFFICER | Sale | 25,000 | $793K | May 4 | SEC ↗ |
Related companies
CAPRICOR THERAPEUTICS, INC. is in the Healthcare sector.